BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16038254)

  • 1. Independent evaluation of GAEL.
    Talhari S; Penna G
    Lepr Rev; 2005 Jun; 76(2):180-1. PubMed ID: 16038254
    [No Abstract]   [Full Text] [Related]  

  • 2. An evaluation of GAEL, the Global Alliance for the Elimination of Leprosy.
    Braber KL
    Lepr Rev; 2004 Sep; 75(3):208-13. PubMed ID: 15508896
    [No Abstract]   [Full Text] [Related]  

  • 3. What lessons can we learn from the evaluation of GAEL?
    Durston T
    Lepr Rev; 2004 Sep; 75(3):214-6. PubMed ID: 15508897
    [No Abstract]   [Full Text] [Related]  

  • 4. The place of leprosy in the control-elimination-eradication spectrum.
    Awofeso N
    Bull World Health Organ; 2005 Jul; 83(7):558. PubMed ID: 16175832
    [No Abstract]   [Full Text] [Related]  

  • 5. The Global Alliance for the Elimination of Leprosy (GAEL).
    Vasey T
    Lepr Rev; 2000 Sep; 71(3):253-5. PubMed ID: 11105482
    [No Abstract]   [Full Text] [Related]  

  • 6. Comments on the report entitled 'Independent evaluation of the Global Alliance for the Elimination of Leprosy'.
    Ji B
    Lepr Rev; 2004 Sep; 75(3):217-20. PubMed ID: 15508898
    [No Abstract]   [Full Text] [Related]  

  • 7. Leprosy control in a prefecture of Yunnan Province in the Peoples' Republic of China, using intensive health education of the public and primary health care workers for the detection of cases, 1998-1999.
    Huan-Ying L; Shun-Peng R; Rong-De Y
    Lepr Rev; 2002 Mar; 73(1):84-7. PubMed ID: 11969134
    [No Abstract]   [Full Text] [Related]  

  • 8. Leprosy program in India at the crossroads.
    Rao PN
    Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):211-5. PubMed ID: 16830645
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence: a valid indicator for monitoring leprosy "elimination"?
    Declercq E
    Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2):111-3. PubMed ID: 11757167
    [No Abstract]   [Full Text] [Related]  

  • 10. 25 years of MDT: a caveat.
    Soutar D
    Lepr Rev; 2004 Dec; 75(4):406. PubMed ID: 15682979
    [No Abstract]   [Full Text] [Related]  

  • 11. Sustainability of leprosy control services in low-endemic situations.
    Feenstra P
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):599-608. PubMed ID: 7868960
    [No Abstract]   [Full Text] [Related]  

  • 12. Health systems research training as a tool for more effective Hansen's disease control programmes in Brazil.
    Ramos AN; Heukelbach J; Gomide M; Hinders DC; Schreuder PA
    Lepr Rev; 2006 Sep; 77(3):175-88. PubMed ID: 17171998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leprosy: too complex a disease for a simple elimination paradigm.
    Lockwood DN; Suneetha S
    Bull World Health Organ; 2005 Mar; 83(3):230-5. PubMed ID: 15798849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The leprosy problem in the South Pacific.
    Crawford C
    N Z Med J; 2014 May; 127(1394):91-3. PubMed ID: 24929576
    [No Abstract]   [Full Text] [Related]  

  • 15. The decentralization of the health system in Colombia and Brazil and its impact on leprosy control.
    Kalk A; Fleischer K
    Lepr Rev; 2004 Mar; 75(1):67-78. PubMed ID: 15072128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reflections on the new WHO leprosy indicator: the rate of new cases with grade 2 disabilities per 100,000 population per year.
    Declercq E
    Lepr Rev; 2011 Mar; 82(1):3-5. PubMed ID: 21644466
    [No Abstract]   [Full Text] [Related]  

  • 17. Supporting 'the individual' with leprosy: the need for a 'post-elimination strategy'.
    Porter JD
    Lepr Rev; 2004 Mar; 75(1):2-6. PubMed ID: 15072121
    [No Abstract]   [Full Text] [Related]  

  • 18. Leprosy elimination--how far?
    Gupta V; Kumar B; Dogra S; Vasudev U; Kaur I
    Lepr Rev; 2004 Mar; 75(1):101-2. PubMed ID: 15072134
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of chronic diseases: an overview of the Brazilian governmental leprosy program.
    Souza AD; el-Azhary RA; Foss NT
    Int J Dermatol; 2009 Feb; 48(2):109-16. PubMed ID: 19200181
    [No Abstract]   [Full Text] [Related]  

  • 20. WHO leprosy elimination campaign--beyond 2005.
    Braber KL
    Lepr Rev; 2000 Sep; 71(3):389-91. PubMed ID: 11105501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.